Apparatus and apparatus control method for the quantitative concentration determination of selected substances filtered out of a patient's body in a fluid

Patent metadata

Field	Value
Publication number	US-9423338-B2
Application number	US-201514691208-A
Country	US
Kind code	B2
Filing date	Apr 20, 2015
Priority date	May 8, 2014
Publication date	Aug 23, 2016
Grant date	Aug 23, 2016

Abstract

Methods and apparatus are disclosed for determining a substance in a fluid excreted/extracted from the body or spent dialysate, e.g., for determining a quality measure for the dialysis, such as the concentration of selected toxic substances, and/or for determining a removed total quantity of uremic toxins during a dialysis with a dialysis apparatus. A concentration of a substance in the fluid may be determined by: detecting, by an absorption sensor, a first extinction signal of the fluid at an analysis wavelength at a defined first pH value of the fluid; adjusting, by a pH adjusting device, a second pH value of the fluid which differs from the first pH value; detecting, by the absorption sensor, a second extinction signal of the fluid at the analysis wavelength at the second pH value; and processing/comparing the two extinction signals for the first and the second pH values and determining an absolute concentration of the substance dissolved in the fluid.

First claim

The invention claimed is:

1. An apparatus for quantitative concentration determination of selected or selectable substances such as uremic toxins in a fluid, comprising:
an optical absorption sensor adapted to detect at least one first extinction signal of the fluid at at least one analysis wavelength at a first pH value of the fluid;
a pH device adapted to adjust the fluid to a second pH value that differs from the first pH value;
the optical absorption sensor further adapted to detect at least one second extinction signal of the fluid at the at least one analysis wavelength at the second pH value;
a signal processing device adapted to process the two extinction signals at the first and the second pH values to obtain a result;
a determination device adapted to determine at least one of an absolute concentration or a signal proportional to the concentration of at least one selected or selectable substance in the fluid on the basis of the result of the signal processing device; and
an analysis wavelength adjusting device adapted to adjust the analysis wavelength to a value at which the selected or selectable substance changes its absorption property if the pH value changes.

2. The apparatus of claim 1 , wherein the fluid is excreted from a body, is extracted from the body, or is an extracorporeal blood purification fluid.

3. The apparatus according to claim 1 , wherein the analysis wavelength adjusting device is adapted to adjust the analysis wavelength to a value at which a non-selected substance does not or negligibly change its absorption property with respect to the signal processing device if the pH value is changed.

4. The apparatus according to claim 1 , wherein the apparatus is adapted to analyze a dialysate, blood, plasma, urine or similar medical/biological solvents by means of the optical absorption sensor.

5. The apparatus according to claim 1 , wherein the optical absorption sensor is a single wavelength sensor using only a signal with a single predefined or selectable analysis wavelength in the scope of an analysis process.

6. The apparatus according to claim 1 , wherein the pH device is adapted to adjust the first pH value to approximately 7.3.

7. The apparatus according to claim 1 , wherein the pH device changes the pH value of the fluid by using an electrolytic method by means of an electrolytic cell or by adding acids, bases and gases, such as CO 2 .

8. The apparatus according to claim 7 , wherein the pH device is adapted to determine at least one of the first or the second pH value by means of a respective mixing ratio between the fluid and an additive changing the at least one pH value.

9. The apparatus according to claim 1 , wherein, in the case of overlapping absorption bands of the selected substance and at least one further, non-selected substance, the absorption sensor operates at an isosbestic wavelength of the non-selected substance.

10. The apparatus according to claim 9 , wherein the analysis wavelength is at least one of approximately 254 nm for the analysis of creatinine, corresponding to the isosbestic point of uric acid or approximately 300 nm for the analysis of uric acid.

11. The apparatus according to claim 1 , wherein at least one of the absorption sensor or a light source for the absorption sensor operate in a wavelength range with a range of substantially +/−1 nm to 5 nm.

12. A method for the quantitative concentration determination of selected or selectable substances such as uremic toxins in a fluid, preferably for the determination of a quality measure for the dialysis such as the concentration of selected toxic substances or for the determination of a removed total quantity of uremic toxins during the dialysis with a dialysis apparatus, wherein the method comprises the steps of:
detecting, by an optical absorption sensor, at least one first extinction signal of the fluid at at least one analysis wavelength at a first pH value of the fluid;
adjusting, by a pH adjusting device, the fluid to a second pH value of the fluid which differs from the first pH value;
detecting, by the absorption sensor, at least one second extinction signal of the fluid at the analysis wavelength at the second pH value;
processing the two extinction signals at the first and the second pH values to obtain a result and determining an absolute concentration or a signal proportional to the concentration of at least one selected substance dissolved in the fluid on the basis of the result of processing; and
adjusting, with an analysis wavelength adjusting device, the analysis wavelength to a value at which the selected or selectable substance changes its absorption property if the pH value changes.

13. The method according to claim 12 , wherein the fluid is excreted from a body, extracted from the body, or is an extra corporeal blood purification fluid.

14. The method of claim 12 , wherein the result is obtained by calculating a difference between the two extinction signals.

15. The method according to claim 12 , wherein in the case of overlapping absorption bands of the selected substance and at least one further, non-selected substance, the at least one predetermined analysis wavelength is an isosbestic analysis wavelength with respect to the non-selected substance.

16. The method according to claim 15 , wherein the at least one predetermined analysis wavelength is adjusted to approximately 254 nm for the analysis of creatinine, corresponding to the isosbestic point of uric acid and/or approximately 300 nm for the analysis of uric acid.

Assignees

• Braun Avitum Ag

Inventors

• Alic Miran
• Strohhoefer Christof
• Janik Waldemar

Classifications

• G01N21/33

  using ultraviolet light (G01N21/39 takes precedence) · CPC title

• A61M1/1617 Primary

  using measurements made during a temporary variation of a characteristic of the fresh dialysis fluid · CPC title

• G01N21/3103

  Atomic absorption analysis · CPC title

• G01N2800/347

  Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy · CPC title

• A61M2205/3313

  used specific wavelengths · CPC title